Home » Topics » BioWorld Science

BioWorld Science
RSS

5-HT2B/2C antagonists disclosed by SKB

Oct. 4, 1996

Novel benzodiazepine derivatives from Roche

Oct. 4, 1996

Introduction of integrated test for breast and ovarian cancer ahead of schedule

Oct. 4, 1996

Antex awarded SBIR grant for diagnostic tests

Oct. 4, 1996

Broad patent coverage for Sonus's ultrasound contrast agents

Oct. 4, 1996

Promising clinical results with gastrointestinal cancer diagnostic

Oct. 4, 1996

Japanese licensing agreement for Geron's telomerase detection technology

Oct. 4, 1996

U.S. Bioscience and Schering-Plough revise Ethyol agreement

Oct. 4, 1996

VX-853 for MDR reversal receives patent coverage

Oct. 4, 1996

Inhibitors of endothelial cell proliferation from Sumitomo

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026